Qiagen NV Stock Statistic Functions Linear Regression Intercept

QGEN Stock  USD 41.21  -1.79  -4.16%   
The statistic functions module provides an execution environment for Linear Regression Intercept function and related indicators on Qiagen NV. Signals here center on statistical functions describing dispersion and variability alongside volatility and performance references.Please specify Time Period to run the technical study.

Function
Time Period
Execute Function
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Intercept is the expected mean value of Qiagen NV price seriese where values of its benchmark or peer price series are zero.

Qiagen NV Technical Analysis Modules

Most technical analysis of Qiagen NV help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Qiagen from various momentum indicators to cycle indicators. When you analyze Qiagen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

The stock is currently in a sell-off trend.QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Qiagen NV operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 6200 people. The profile for Qiagen NV integrates fundamentals, price behavior, and sector exposure. The asset's responsiveness to economic cycles appears relatively balanced. Qiagen NV has a market cap of 8.47 B, P/E of 24.32, ROE of 11.57%.

Methodology

Unless otherwise specified, financial data for Qiagen NV is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Qiagen (USA Stocks:QGEN) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Qiagen NV is covered by 17 analysts. 8 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include HSBC Global Research, Wells Fargo Securities, Goldman Sachs, Guggenheim Securities, RBC Capital Markets, Citigroup, Jefferies, Evercore ISI, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Align your values with your investing style

Using Qiagen NV inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
FinTech Idea
FinTech
Invested over 20 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 200 shares
Driverless Cars Idea
Driverless Cars
Invested few shares

More Resources for Qiagen Stock Analysis

A structured review of Qiagen NV often starts with core financial statements and trend context. Ratios and trend metrics help frame Qiagen NV's operating context. Key reports that frame Qiagen NV Stock are listed below:
Qiagen NV has a market cap of 8.47 B, operating margin of 25.38%, ROE of 11.57%. Use Your Equity Center to explore allocation context. This includes a position in Qiagen NV in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.
Analysis related to Qiagen NV should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Stocks Directory module to find actively traded stocks across global markets.
 Quarterly Earnings Growth
0.219
 Dividend Share
0.263
 Earnings Share
2.04
 Revenue Per Share
10.051
 Quarterly Revenue Growth
0.037
The market value of Qiagen NV is measured differently than book value, which reflects Qiagen accounting equity. Qiagen NV's market capitalization is 8.47 B. A P/B ratio of 2.25 indicates the market values Qiagen NV above its accounting book value. Enterprise value stands at 9.04 B. Value and price for Qiagen NV are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Qiagen NV's intrinsic value and market price are different measures derived from different inputs. For Qiagen NV, key inputs include a P/E ratio of 24.32, a P/B ratio of 2.25, a profit margin of 20.33%, and ROE of 11.57%. Market price reflects the current exchange level formed by active bids and offers.